Midecamycin is an orally available, broad spectrum macrolide antibiotic produced by Streptomyces mycarofaciens that targets bacterial the 50S ribosomal subunit.
The Journal of organic chemistry, 87(15), 9688-9698 (2022-07-09)
Seeking to improve the site selectivity of acylation of amphiphilic diols, which is induced by imidazole-based nucleophilic catalysts and directs the reaction toward apolar sites, as we recently reported, we examined a new improved catalytic design and an alteration of
[Splenic contraction in patients with various disorders].
A Iio et al.
Kaku igaku. The Japanese journal of nuclear medicine, 23(3), 259-266 (1986-03-01)
The Japanese journal of antibiotics, 35(6), 1462-1474 (1982-06-01)
In vitro midecamycin acetate was shown to have broad spectrum of antibacterial activities similar to those of other macrolides (midecamycin, josamycin, 9-propionyl josamycin and 2'-ethylsuccinyl erythromycin), which include Gram-positive organisms, a part of Gram-negative organisms and anaerobes. Metabolites of midecamycin
Domande
Recensioni
★★★★★ Nessuna valutazione
Filtri attivi
Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..
